Patent Approval Sparks SINTX Technologies Shares Surge
SINTX Technologies Inc (SINT) saw a dramatic 91.5% surge in its shares price to $5.40 on Monday. However, SINTX Technologies shares are currently in correction, trading at $3.65, down from a peak of $5.40. This surge followed the receipt of a Notice of Allowance from the U.S. Patent and Trademark Office. The patent pertains to zirconia-toughened alumina (ZTA) surface functionalization methods.
Technology Overview
The newly approved patent covers methods for bonding bioactive silicon nitride, or a silicon nitride-bioactive glass mixture, to ZTA surfaces. This technology aims to integrate silicon nitride’s properties into the typically inert ZTA substrates. Such properties include enhanced osseointegration and bacterial resistance. These features are crucial for medical device manufacturing.
CEO’s Statement
Eric K. Olson, President and CEO of SINTX, highlighted that the patent allowance signifies a step forward in the company’s intellectual property portfolio. Olson emphasized that this progress supports SINTX’s efforts to develop new biomaterials for medical applications.
Recent Developments
Currently, SINTX is the only FDA-registered producer of implantable silicon nitride. Recently, the company introduced a particulate form of this material. This new form can be used in composites and coatings, broadening its application potential.
SINTX Technologies Shares – Performance and Market Data
Despite the significant initial surge, SINTX Technologies shares are experiencing a correction. As of Tuesday, the stock is trading lower at $3.65. The company’s market capitalization stands at $2.75 million, with revenue of $3.13 million and a net income of -$8.60 million. The stock has 747.29K shares outstanding and an EPS of -$66.52. Its beta is 1.40, reflecting higher volatility. Trading volume is 884,794, with the stock opening at $4.18 and closing the previous day at $4.36. The day’s trading range is between $3.62 and $4.26, while the 52-week range spans from $2.75 to $212.00.
Analyst Recommendations
Analysts have given SINTX a “Hold” rating. There is no current price target or forward PE ratio available. The stock’s beta of 1.40 suggests higher volatility compared to the broader market.
Future Outlook
The recent patent allowance may contribute to long-term growth. However, the stock’s recent correction highlights potential short-term volatility. Investors should monitor further developments and financial performance as SINTX continues to advance its technological portfolio and expand its product offerings.
SINTX Technologies stands at a pivotal moment. The company’s recent patent success could mark significant growth opportunities, though current stock fluctuations reflect ongoing investor caution.
Chart by Trading View
